Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy and porphyria: new perspectives.

Carlo Solinas1, Frank J Vajda

  • 1Australian Centre for Clinical Neuropharmacology - Raoul Wallenberg Centre, Centre for Clinical Neuroscience, St. Vincent's Hospital, University of Melbourne, Vic., Australia. solinac@svhm.org.au

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|April 15, 2004
PubMed
Summary

Porphyria, a disorder of haem biosynthesis, can cause neurological issues like seizures. Some antiepileptic drugs may trigger porphyria, necessitating careful drug assessment and patient monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Neurology·2026
Same author

Risk of Adverse Pregnancy Outcomes Associated With Antiseizure Medications and Their Indications: A Systematic Review and Meta-Analysis.

Neurology·2025
Same author

Paternal exposure to antiseizure medications and offspring outcomes: a systematic review.

Journal of neurology, neurosurgery, and psychiatry·2024
Same author

Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Antiseizure Medication: A Systematic Review.

Neurology·2024
Same author

Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications.

Neurology·2022
Same author

Valproate under threat.

The Australian and New Zealand journal of psychiatry·2019

Area of Science:

  • Biochemistry
  • Neurology
  • Genetics

Background:

  • Porphyria encompasses disorders of the haem biosynthesis pathway.
  • Neurological manifestations, particularly seizures, are significant clinical features.
  • Seizures may stem from metabolic disturbances and the neurotoxic effects of porphyrins.

Purpose of the Study:

  • To explore the link between porphyria and seizures.
  • To assess the safety of newer antiepileptic drugs (AEDs) in porphyria patients.
  • To propose strategies for improved understanding and management of porphyria-related epilepsy.

Main Methods:

  • Review of existing literature on porphyria and seizures.
  • Analysis of potential triggers for porphyria attacks, including AEDs.

Related Experiment Videos

  • Discussion of diagnostic and management approaches, including registries and neuroimaging.

    • Main Results:

    • Porphyric attacks can lead to neural damage, potentially causing epilepsy.
    • Certain AEDs are known to precipitate porphyria, requiring cautious use.
    • Emerging AEDs require evaluation for porphyria-precipitating potential.

    Conclusions:

    • Understanding the pathogenesis of seizures in porphyria is crucial.
    • Careful selection and monitoring of AEDs are essential for patients with porphyria.
    • Further research, patient registries, and genetic studies can enhance porphyria management and epilepsy risk assessment.